Pharvaris N.V. (PHVS) Stock Forecast
PHVS analyst forecast
as of October 18, 2026- Analyst consensus
- Strong buy 4.64 / 5 from 14 analysts
- Price target
- $57.76 average of analyst targets
- Upside to target
- +108.2% from the latest close
- Next earnings
- November 11, 2026 EPS estimate $-0.82
- 52-week range
- $21.59 – $38.86
PHVS analyst ratings
14 analystsNumber of analysts at each rating.
PHVS price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
PHVS earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.72 | −$0.80 | −$0.67 | −$0.60 | −19.9% | 11 |
| Current fiscal year (2026) | −$2.77 | −$3.01 | −$2.39 | −$2.97 | +6.6% | 13 |
| Next fiscal year (2027) | −$2.72 | −$3.53 | −$2.11 | −$2.77 | +1.9% | 12 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
PHVS revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0 | $0 | $0 | 0.0% | 9 |
| Current fiscal year (2026) | $0 | $0 | $0 | 0.0% | 10 |
| Next fiscal year (2027) | $32.2M | $3.3M | $54.4M | 0.0% | 12 |
PHVS EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
PHVS revenue: reported and forecast
PHVS EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.66 | −$0.67 | −$0.72 | −$0.72 | −$0.72 | +8.9% | 3 up · 8 down |
| Current fiscal year (2026) | −$2.62 | −$2.65 | −$2.77 | −$2.77 | −$2.77 | +5.9% | 2 up · 9 down |
| Next fiscal year (2027) | −$2.35 | −$2.52 | −$2.71 | −$2.71 | −$2.72 | +15.8% | 3 up · 8 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
PHVS earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; PHVS beat in 5 of 12.
What analysts expect from PHVS
14 analysts cover Pharvaris; their consensus rating is strong buy (4.64 on a 1–5 scale, where 5 is a strong buy). The average price target is $57.76, 108.2% above the latest close of $27.74. Analysts expect earnings of −$2.77 per share for 2026, +6.6% from a year earlier. For 2027 the average estimate is −$2.72 per share on revenue of $32.2 million. Pharvaris beat the EPS estimate in 5 of the last 12 quarters.
Related: PHVS income statement, PHVS key metrics, PHVS chart. See the PHVS stock overview for the latest quote and news.
PHVS forecast FAQ
What is Pharvaris's price target?
The average analyst price target for Pharvaris is $57.76, 108.2% above the latest close of $27.74.
Is Pharvaris a buy, hold or sell?
Of 14 analysts covering Pharvaris, 10 rate it a strong buy, 3 a buy, 1 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Pharvaris's EPS forecast?
Analysts forecast −$2.77 per share for 2026 (range −$3.01 to −$2.39); for 2027 the estimate is −$2.72.
When does Pharvaris report earnings?
Pharvaris is expected to report results for the quarter ending September 30, 2026 on November 11, 2026; the EPS estimate is $-0.82.
Does Pharvaris usually beat earnings estimates?
Pharvaris reported EPS at or above the analyst estimate in 5 of the last 12 quarters.